TECHNOLOGY FUNDING VENTURE PARTNERS IV
10-Q, 1999-08-16
Previous: FRAGRANCENET COM INC, 10QSB, 1999-08-16
Next: AIM INVESTMENT FUNDS, 497, 1999-08-16



<PAGE>

                            UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.  20549

                              FORM 10-Q

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

              For the quarterly period ended June 30, 1999

                                 OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

            For the transition period from N/A to N/A
                                           ---    ---

                      Commission File No. 814-55

TECHNOLOGY FUNDING VENTURE PARTNERS IV, AN AGGRESSIVE GROWTH FUND, L.P.
- -----------------------------------------------------------------------
         (Exact name of Registrant as specified in its charter)

          Delaware                         94-3054600
 ------------------------------     ---------------------------------
(State or other jurisdiction of    (I.R.S. Employer Identification No.)
incorporation or organization)

2000 Alameda de las Pulgas, Suite 250
San Mateo, California                                            94403
- -------------------------------------                        ---------
(Address of principal executive offices)                     (Zip Code)

                              (650) 345-2200
             --------------------------------------------------
            (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.  Yes X  No
                                                              ---   ---
No active market for the units of limited partnership interests
("Units") exists, and therefore the market value of such Units cannot be
determined.


<PAGE>

I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

BALANCE SHEETS
- --------------

<TABLE>
<CAPTION>

                                         (unaudited)
                                           June 30,         December 31,
                                            1999               1998
                                         -----------        -----------
<S>                                     <C>                 <C>
ASSETS

Investments:
 Equity investments (cost basis
  of $13,282,887 and $12,547,986 for
  1999 and 1998, respectively)          $17,070,662         15,647,313
 Notes receivable (cost basis of
  $189,239 and $202,777 for 1999 and
  1998, respectively)                       189,239            202,777
                                         ----------         ----------
     Total investments                   17,259,901         15,850,090

Cash and cash equivalents                     7,134          1,188,918
Due from related parties                         --             29,771
Other assets                                 15,177              5,179
                                         ----------         ----------

     Total assets                       $17,282,212         17,073,958
                                         ==========         ==========

LIABILITIES AND PARTNERS' CAPITAL

Accounts payable and accrued expenses   $    73,403             48,922
Due to related parties                       59,826                 --
Distributions payable                       370,130            370,130
Other liabilities                            14,269             13,914
                                         ----------         ----------

     Total liabilities                      517,628            432,966

Commitments, contingencies and
 subsequent event (Notes 3, 7, 8,
 and 9)

Partners' capital:
 Limited Partners
  (400,000 Units outstanding)            12,742,257         13,170,018
 General Partners                           234,552            371,647
 Net unrealized fair value increase
  from cost of equity investments         3,787,775          3,099,327
                                         ----------         ----------

     Total partners' capital             16,764,584         16,640,992
                                         ----------         ----------

     Total liabilities and
      partners' capital                 $17,282,212         17,073,958
                                         ==========         ==========
</TABLE>

See accompanying notes to financial statements.

<PAGE>
STATEMENTS OF OPERATIONS (unaudited)
- -----------------------------------
<TABLE>
<CAPTION>
                                               For the Three                 For the Six
                                               Months Ended                  Months Ended
                                                 June 30,                      June 30,
                                        -------------------------       ----------------------
                                            1999          1998            1999          1998
                                            ----          ----            ----          ----
<S>                                   <C>             <C>             <C>          <C>
Income:
 Notes receivable interest             $   10,836             --          21,120           --
 Short-term investment interest             1,252         29,841           7,384       60,594
                                        ---------      ---------         -------    ---------
  Total income                             12,088         29,841          28,504       60,594

Costs and expenses:
 Management fees                           40,385         49,425          83,070      107,099
 Individual General Partners'
  compensation                             11,337         10,301          20,006       19,916
 Operating expenses:
  Administrative and investor services    181,491        142,037         319,141      318,153
  Investment operations                    65,611         45,924         144,369      192,047
  Professional fees                        49,889         19,380          61,749       31,395
  Computer services                        30,478         34,865          58,914      126,797
                                        ---------      ---------         -------    ---------
     Total operating expenses             327,469        242,206         584,173      668,392
                                        ---------      ---------         -------    ---------
     Total costs and expenses             379,191        301,932         687,249      795,407
                                        ---------      ---------         -------    ---------
Net operating loss                       (367,103)      (272,091)       (658,745)    (734,813)


 Realized gain (loss) from
  sales of equity investments                  --         73,410         (30,464)    (108,761)
 Net realized gain from venture
  capital limited partnership
  investments                              60,692             --         126,968           --
 Realized losses from investment
  write-downs                              (2,615)            --          (2,615)          --
 Recoveries from investments
  previously written off                       --          3,650              --        3,650
                                        ---------      ---------         -------    ---------
Net realized loss                        (309,026)      (195,031)       (564,856)    (839,924)

Change in net unrealized
  fair value of equity investments      1,352,222      1,771,262         688,448    2,751,753
                                        ---------      ---------         -------    ---------

Net income                             $1,043,196      1,576,231         123,592    1,911,829
                                        =========      =========         =======    =========

Net realized loss per Unit             $    (0.59)         (0.39)          (1.07)       (1.68)
                                        =========      =========         =======    =========
</TABLE>

See accompanying notes to financial statements.

<PAGE>
STATEMENTS OF CASH FLOWS (unaudited)
- -----------------------------------
<TABLE>
<CAPTION>
                                         For the Six Months Ended June 30,
                                         --------------------------------
                                             1999                1998
                                          ----------         ----------
<S>                                      <C>                 <C>
Cash flows from operating activities:
 Interest received                      $   16,015              60,902
 Cash paid to vendors                     (215,259)           (113,938)
 Cash paid to related parties             (367,555)           (828,137)
                                         ---------           ---------

  Net cash used by operating activities   (566,799)           (881,173)
                                         ---------           ---------

Cash flows from investing activities:
 Purchase of equity investments           (698,868)           (979,997)
 Notes receivable issued                  (183,333)            (16,598)
 Repayments of notes receivable            198,844             204,848
 Proceeds from sales of equity
  investments                               68,372             319,860
 Recoveries from investments previously
  written off                                   --               3,650
                                         ---------           ---------

  Net cash used by
   investing activities                   (614,985)           (468,237)
                                         ---------           ---------

Cash flows from financing activities:
  Distribution to partners                      --          (3,544,571)
                                         ---------           ---------

  Net cash used by financing
   activities                                   --          (3,544,571)
                                         ---------           ---------

Net decrease in cash
  and cash equivalents                  (1,181,784)         (4,893,981)

Cash and cash equivalents at
  beginning of year                      1,188,918           8,821,077
                                         ---------           ---------
Cash and cash equivalents               $    7,134           3,927,096
  at June 30                             =========           =========

See accompanying notes to financial statements.
</TABLE>

<PAGE>

STATEMENTS OF CASH FLOWS (unaudited)(continued)
- -----------------------------------------------
<TABLE>
<CAPTION>
                                       For the Six Months Ended June 30,
                                       ------------------------------------
                                            1999                 1998
                                        -----------          -----------
<S>                                    <C>                   <C>
Reconciliation of net income to net
 cash used by operating activities:

Net income                              $  123,592           1,911,829

Adjustments to reconcile net income
 to net cash used by operating
 activities:
  Net realized loss from sales
   of equity investments                    30,464             108,761
  Realized gain from venture
   capital limited partnership
   investments                            (126,968)                 --
  Realized losses from investment
   write-downs                               2,615                  --
  Recoveries from investments previously
   written off                                  --              (3,650)
  Change in net unrealized fair value
   of equity investments                  (688,448)         (2,751,753)

Changes in:
 Due to/from related parties                89,597            (136,310)
 Other changes, net                          2,349             (10,050)
                                         ---------           ---------
Net cash used by operating activities   $ (566,799)           (881,173)
                                         =========           =========

</TABLE>

See accompanying notes to financial statements.

<PAGE>

NOTES TO FINANCIAL STATEMENTS (unaudited)
- ----------------------------------------

1.     General
       -------

In the opinion of the Managing General Partners, the accompanying interim
financial statements reflect all adjustments necessary for a fair
presentation of the financial position, results of operations, and cash
flows for the interim periods presented.  These statements should be read
in conjunction with the Annual Report on Form 10-K for the year ended
December 31, 1998.  Allocation of income and loss to Limited and General
Partners is based on cumulative income and loss.  Adjustments, if any, are
reflected in the current quarter balances.

In April 1999, the Management Committee of the Partnership extended the
term of the Partnership to December 31, 2001.

2.     Financing of Partnership Operations
       -----------------------------------

The Managing General Partners expect cash received from the future
liquidation of Partnership investments and future short-term borrowings
will provide the necessary liquidity to fund Partnership operations.  The
Partnership may be dependent upon the financial support of the Managing
General Partners to fund operations if future proceeds are not received
timely.  The Managing General Partners have committed to support the
Partnership's working capital requirements through short-term advances as
necessary.

3.     Related Party Transactions
       --------------------------

Related party costs are included in costs and expenses shown on the
Statements of Operations.  Related party costs for the six months ended
June 30, 1999 and 1998, were as follows:

<TABLE>
<CAPTION>
                                                 1999          1998
                                               --------      --------
   <S>                                        <C             <C>
   Management fees                            $ 83,070       107,099
   Individual General Partners' compensation    20,006        19,916
   Reimbursable operating expenses             354,076       564,812

</TABLE>

Certain reimbursable expenses have been accrued based upon interim
estimates prepared by the Managing General Partners and are adjusted to
actual periodically.  There were $46,364 due to and $40,957 due from
related parties at June 30, 1999 and December 31, 1998 respectively,
related to such expenses.


Amounts payable for management fees were $13,462 and $11,186 at June 30,
1999, and December 31, 1998, respectively.  Pursuant to the Partnership
Agreement, quarterly management fees are equal to one quarter of one
percent of the fair value of Partnership assets.

Officers of the Managing General Partners occasionally receive stock
options as compensation for serving on the Boards of Directors of portfolio
companies.  At June 30, 1999, the Partnership had an indirect interest in
Endocare, Inc., Physiometrix, Inc., Thermatrix Inc., and UroGen Corp., non-
transferable options with a total fair market value of $43,417.



<PAGE>

4.     Equity Investments
       ------------------
<TABLE>
A full listing of the Partnership's equity investments at December 31, 1998, is in the 1998 Annual
Report on Form 10-K.  Activity from January 1 through June 30, 1999, consisted of:
<CAPTION>

                                                                     January 1 through June 30, 1999
                                                                     -------------------------------
                                                          Principal
                                          Investment      Amount or        Cost           Fair
Industry/Company         Position            Date           Shares         Basis          Value
- ----------------         --------         ----------      ---------       -------        -------
<S>                    <C>                 <C>            <C>            <C>         <C>
Balance at January 1, 1999                                             $12,547,986     15,647,313
                                                                        ----------     ----------

Significant changes:

Communications
- --------------

Women.com Networks      Series A
                        Preferred
                        shares               02/96            6,098              0         40,918
Women.com Networks      Series B
                        Preferred
                        shares               02/96            7,452              0         50,003
Women.com Networks      Series C
                        Preferred
                        shares               07/97           35,295              0        236,829
Women.com Networks      Series D
                        Preferred
                        shares               06/98           91,185              0        611,851
Women.com Networks      Series E
                        Preferred
                        shares               05/99            8,666         86,660         86,660


Computer Equipment Systems and Software
- ---------------------------------------
Pilot Network
 Services, Inc.         Common shares        02/99 &          4,367         56,689         43,087
                                             05/99            3,393         60,692         32,700

Environmental
- -------------
Naiad Technologies,     Series A, B and
 Inc.                   C Preferred
                        shares               12/95-11/97    161,832              0       (215,753)
Thermatrix Inc.         Common shares        06/96        1,105,847              0        349,277

Information Technology
- ----------------------
WorldRes, Inc.          Series B and C
                        Preferred shares     01/97-12/97    128,645              0        302,315
WorldRes, Inc.          Series D
                        Preferred shares     03/99           27,273        165,002        165,002

Medical/Biotechnology
- ---------------------
Biex, Inc.              Series A, B, C,
                        D and E Preferred
                        shares               07/93-08/97    629,794              0        109,942
Biex, Inc.              Series F
                        Preferred shares     03/99          132,743        345,132        345,132
Endocardial Solutions,
 Inc.                   Common shares        09/97            5,714        (80,710)       (58,140)
Endocare, Inc.          Common shares        08/96-04/98     46,014              0        131,117
Inhale Therapeutic
 Systems, Inc.          Common shares        12/95-03/97     28,952              0       (263,116)
UroGen Corp.            Convertible note     06/98         $250,000       (260,401)      (260,401)
UroGen Corp.            Common shares        06/99          438,366        320,242        112,222

Microelectronics
- ----------------
KOR Electronics, Inc.   Series E
                        Preferred
                        shares               01/94        1,130,390              0       (423,896)

Venture Capital Limited Partnerships
- ------------------------------------
Various                 Limited Partnership
                        interests            Various     $2,333,764         15,000        (96,711)
                                                                        ----------     ----------
Total significant changes during the six
months ended June 30, 1999                                                 708,306      1,299,038

Other changes, net                                                          26,595        124,311
                                                                        ----------     ----------
Total equity investments at June 30, 1999                              $13,282,887     17,070,662
                                                                        ==========     ==========

</TABLE>


Marketable Equity Securities
- ----------------------------

At June 30,1999 and December 31, 1998, marketable equity securities had
aggregate costs of $3,303,758, and $3,204,508, respectively, and aggregate
market values of $2,880,182 and $2,967,543, respectively.  The net
unrealized losses at June 30, 1999, and December 31, 1998, included gross
gains of $648,570 and $819,176, respectively.

Biex, Inc.
- ----------

In March 1999, the Partnership purchased 132,743 Series F Preferred shares
for $345,132.  The pricing of this round, in which third parties
participated, indicated a $69,407 increase in the fair value of the
Partnership's investment in the company's preferred shares and warrants.
In May 1999, the Partnership received a stock dividend of 18,787 Preferred
shares with a fair value of $48,854.

Endocardial Solutions, Inc.
- ---------------------------

In March 1999, the Partnership sold its entire investment in the company
for proceeds of $50,246 and realized a loss of $30,464.

KOR Electronics, Inc.
- ---------------------

In March 1999, the Partnership recorded a $423,896 decrease in the fair
value of its investment in the company based upon the operating status of
the company.

Naiad Technologies, Inc.
- -----------------------------

In June 1999, the Partnership recorded a $215,753 decrease in the fair
value of its investment based upon the Managing General Partners'
assessment of the operating status of the company.

UroGen Corp.
- ------------

In April 1999, the Partnership issued a $50,000 convertible note to the
company.  In June 1999, this note together with previously issued notes and
accrued interest thereon totaling $320,242 were converted to 438,366 common
shares.

Women.com Networks
- ------------------

In May 1999, the Partnership purchased 8,666 Series E Preferred shares for
$86,660.  The pricing of this round, in which third parties participated,
indicated a $939,601 increase in the fair value of the Partnership's
existing investment.

WorldRes, Inc.
- --------------

In March 1999, the Partnership made an additional investment in the company
by purchasing 27,273 Series D Preferred shares for $165,002.  The pricing
of this round, in which third parties participated, indicated a $318,165
increase in the fair value of the Partnership's investment in the company's
preferred shares and warrants.

Venture Capital Limited Partnerships
- ------------------------------------

The Partnership received stock distributions of Pilot Network Services,
Inc. and Rogue Wave Software, Inc. with fair values totaling $126,968.
These distributions were recorded as realized gains.  The Partnership
recorded a $96,711 net decrease in fair value as a result of distributions
from the partnerships which were partially offset by an increase in the
fair value of the underlying investments of the partnerships.

Other Equity Investments
- ------------------------

Other significant changes reflected above relate to market value
fluctuations or the elimination of a discount relating to selling
restrictions for publicly traded portfolio companies.  Portions of the
Partnership's Physiometrix, Inc. and  Thermatrix Inc. shares are
restricted.

5.     Notes Receivable
       ----------------

Activity from January 1, 1999, through June 30, 1999, consisted of:
<TABLE>
<S>                                                         <C>
Balance at January 1, 1999                                  $202,777

1999 activity:
  Notes issued                                               183,333
  Repayments of notes                                       (198,844)
  Change in interest receivable                                1,973
                                                             -------
Balance at June 30, 1999                                    $189,239
                                                             =======
</TABLE>

The interest rate on notes issued in 1999 is 12%.

6.     Cash and Cash Equivalents
       -------------------------

Cash and cash equivalents at June 30, 1999 and December 31, 1998 consisted
of:

<TABLE>
                                                 1999             1998
                                                ------           ------
<S>                                           <C>              <C>
Demand accounts                                 $  597            30,009
Money-Market accounts                            6,537         1,158,909
                                                 -----         ---------
     Total                                      $7,134         1,188,918
                                                 =====         =========
</TABLE>

At June 30, 1999, the majority of the Partnership's funds were on deposit
at a single financial institution.

7.     Distributions
       -------------

At June 30, 1999, distributions of $370,130, declared in 1998, were payable
to Limited Partners.

8.     Short-Term Borrowings
       ---------------------

The Partnership has a borrowing account with a financial institution.  At
June 30, 1999, the borrowing capacity of this account, which fluctuates
based on collateral value, was $341,995 and there were no outstanding
borrowings; as of August 12, 1999, the outstanding balance was $230,505.
Interest is charged at the prime rate plus one-half percent.  The
Partnership's investment in Inhale Therapeutic Systems, Inc. is pledged as
collateral.

9.     Commitments and Contingencies
       -----------------------------

The Partnership is a party to financial instruments with off-balance-sheet
risk in the normal course of its business.  Generally, these instruments
are commitments for future equity fundings, venture capital limited
partnership investments, equipment financing commitments, or accounts
receivable lines of credit that are outstanding but not currently fully
utilized.  As they do not represent current outstanding balances, these
unfunded commitments are properly not recognized in the financial
statements.  At June 30, 1999, the Partnership had the following unfunded
commitments:

<TABLE>
<CAPTION>

TYPE
- ----
<S>                                                  <C>
Line of credit guarantees                             $615,550
Venture capital limited partnership investments         26,150
                                                       -------
     Total                                            $641,700
                                                       =======
</TABLE>

Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

Liquidity and Capital Resources
- -------------------------------

During the six months ended June 30, 1999, net cash used by operating
activities totaled $566,799.  The Partnership paid management fees of
$80,794 to the Managing General Partners and reimbursed related parties for
operating expenses of $266,755 in 1999.  In addition, $20,006 was paid to
the Individual General Partners as compensation for their services.  Other
operating expenses of $215,259 were paid and interest income of $16,015 was
received.

During the six months ended June 30, 1999, the Partnership funded equity
investments of $698,868 primarily to portfolio companies in the
communications, information technology and medical/biotechnology industries
and issued $183,333 in notes receivable to portfolio companies in the
environmental and medical/biotechnology industries.  Proceeds from the
sales of equity investments were $68,372 and repayments of notes receivable
were $198,844.  At June 30, 1999, the Partnership's unfunded commitments
totaled $641,700.

The Partnership has a borrowing account with a financial institution.  The
borrowing capacity of this account, which fluctuates based on collateral
value, was $341,995 at June 30, 1999 and there were no outstanding
borrowings.  As of August 12, 1999, the outstanding balance was $230,505.
The Partnership's investment in Inhale Therapeutic Systems, Inc. is pledged
as collateral.

Cash and cash equivalents at June 30, 1999, were $7,134.  Future proceeds
from investment sales and future short-term borrowings along with Managing
General Partner support are expected to be adequate to fund Partnership
operations through the next twelve months.

Results of Operations
- ---------------------

    Current quarter compared to corresponding quarter in the preceding year
    -----------------------------------------------------------------------

Net income was $1,043,196 for the quarter ended June 30, 1999, compared to
net income of $1,576,231 during the same period in 1998.  The change was
primarily due to a decrease of $419,040 in the net unrealized fair value of
equity investments and a $85,263 increase in operating expenses.

During the quarter ended June 30, 1999, the increase in equity investment
fair value of $1,352,222 was primarily attributable to increases in
portfolio companies in the communications and environmental industries,
partially offset by decreases in portfolio companies in the
medical/biotechnology industry.  During the same period in 1998, the
increase in fair value of equity investments of $1,771,262 was primarily
attributable to increases in portfolio companies in the environmental
industry, partially offset by decreases in the communications industry.

Total operating expenses were $327,469 and $242,206 for the quarters ended
June 30, 1999 and 1998, respectively.  The increase is primarily
attributable to increased investment monitoring activity , administrative
overhead and professional fees.

Given the inherent risk associated with the business of the Partnership,
the future performance of the portfolio company investments may
significantly impact future operations.

    Current six months compared to corresponding six months in the
    --------------------------------------------------------------
    preceding year
    --------------

Net income was $123,592 for the six months ended June 30, 1999, compared to
net income of $1,911,829 during the same period in 1998. The change was
primarily due to a decrease of $2,063,305 in the net unrealized fair value
of equity investments, partially offset by a $84,219 decrease in operating
expenses.

During the six months ended June 30, 1999, the increase in equity
investment fair value of $688,448 was mainly attributable to portfolio
companies in the communications and information technology industries,
partially offset by decreases in the microelectronics industry.  During the
same period in 1998, the increase of $2,751,753 was primarily attributable
to portfolio companies in the environmental industry.

Total operating expenses were $584,173 and $668,392 for the six months
ended June 30, 1999 and 1998, respectively.  The decrease is attributable
to decreased investment monitoring activities and computer expenses.


YEAR 2000
- ---------

Widespread use of computer programs that use two digits rather than four to
store, calculate, and display year values in dates may cause computer
systems to malfunction in the year 2000, resulting in significant business
delays and disruptions.

    The Partnership's State of Readiness
    ------------------------------------

Computer services are provided to the Partnership by its Managing General
Partner, Technology Funding Inc. ("TFI".)  For several years, TFI has
sought to use Year 2000 compliant storage formats and algorithms in its
internally-developed and maintained systems.  TFI has also completed
initial evaluations of computer systems, software, and embedded
technologies.  Those evaluations confirmed that certain components of its
network server hardware and operating systems, voice mail system, e-mail
system, and accounting software may have Year 2000 compliance issues.
These resources and several less-critical components of the systems
environment were all scheduled as part of normal maintenance and
replacement cycles to be replaced or upgraded as Year 2000 compatible
components became available from vendors during 1998 and 1999.  That
program remains on schedule to provide Year 2000 capable systems timely
without significant expenditures or disruption of Partnership operations.
However, the risk remains that TFI may not be able to verify whether Year
2000 compatibility claims by vendors are accurate, or whether changes
undertaken to achieve Year 2000 compatibility will create other undetected
problems in associated systems.  Therefore, TFI anticipates that Year 2000
compliance testing and maintenance of these systems will continue as needed
into the first quarter of 2000.

As part of Year 2000 evaluation, TFI has also assembled a database listing
its significant suppliers to assess the extent to which it needs to prepare
for any of those parties' potential failure to remediate their Year 2000
compliance issues.  TFI reviewed public Year 2000 statements of those
suppliers and sent questionnaires to mission-critical vendors whose public
statements were not adequate for assessment.  All mission-critical vendors
have responded that they expect to be Year 2000 compliant barring any
unforeseen circumstances.  TFI will continue to monitor its significant
suppliers as part of its Year 2000 evaluation.  However, there can be no
guarantee that the systems of other companies on which TFI relies will be
timely converted, or that failure to convert will not have a material
adverse effect on the Partnership and its operations.  TFI is also working
with the Partnership's portfolio companies to determine the extent to which
their operations are vulnerable to Year 2000 issues.  There can be no
guarantee that the systems of portfolio companies in which the Partnership
has invested will be timely converted, or that their failure to convert
will not have a material adverse effect on the Partnership.

    The Cost to Address Year 2000 Issues
    ------------------------------------

Expenditures in 1999 to date related to Year 2000 issues were not material
to the Partnership's financial statements.  TFI expects that additional
expenditures for Year 2000 compliance will not be material to the
Partnership.

    The Risks Associated with Year 2000 Issues
    ------------------------------------------

Any failure by the portfolio companies in which the Partnership has
invested, or by those portfolio companies' key suppliers or customers, to
anticipate and avoid Year 2000 related problems at reasonable cost could
have a material adverse effect on the value of and/or the timing of
realization of value from the Partnership's investments.  If Year 2000
compliance issues are not resolved by December 31, 1999, internal system
failures or miscalculations could cause a temporary inability to process
transactions, loss of ability to send or receive e-mail and voice mail
messages, or disruptions in other normal business activities.
Additionally, failure of third parties on whom TFI relies to remediate
their Year 2000 issues timely could result in disruptions in the
Partnership's relationship with its financial institutions, temporary
disruptions in processing transactions, unanticipated costs, and problems
related to the Partnership's daily operations.  While TFI continues to
address its internal Year 2000 issues, until TFI receives and evaluates
responses from a significant number of its suppliers, the overall risks
associated with the Year 2000 issue remain difficult to describe and
quantify.  There can be no guarantee that the Year 2000 issue will not have
a material adverse effect on the Partnership and its operations.

    TFI's Contingency Plan
    ----------------------

As part of its normal efforts to assure business continuation in the event
of natural disasters, systems failures, or other disruptions, TFI has
prepared contingency plans including an extensive Year 2000 contingency
plan.  Taken together with TFI's Year 2000 remediation plan, it identifies
potential points of failure, approaches to correcting known Year 2000
problems, dates by which the preferred corrections are anticipated to be
made and tested, and alternative approaches if the corrections are not
completed timely or are later found to be inadequate.  Although backup
systems and contingency approaches have been identified for most mission-
critical systems and vendor dependencies, there remain some systems for
which no good alternative exists, and there may be some problems that prove
more intractable than currently anticipated.


II.  OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

(a)  No reports on Form 8-K were filed by the Partnership during the
     quarter ended June 30, 1999.

(b)  Financial Data Schedule for the six months ended and as of
     June 30, 1999 (Exhibit 27).


<PAGE>




                              SIGNATURES
                              ----------

Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report to be
signed on its behalf by the undersigned, thereunto duly authorized.

                         TECHNOLOGY FUNDING VENTURE PARTNERS IV,
                         AN AGGRESSIVE GROWTH FUND, L.P.

                         By:  TECHNOLOGY FUNDING INC.
                              Managing General Partner




Date:  August 13, 1999   By:      /s/Michael R. Brenner
                            -------------------------------------------
                                     Michael R. Brenner
                                     Controller




<TABLE> <S> <C>

<ARTICLE>6
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE FORM 10-Q AS OF JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
<MULTIPLIER>1
<FISCAL-YEAR-END>             DEC-31-1999
<PERIOD-START>                JAN-01-1999
<PERIOD-END>                  JUN-30-1999
<PERIOD-TYPE>                       6-MOS
<INVESTMENTS-AT-COST>          13,472,126
<INVESTMENTS-AT-VALUE>         17,259,901
<RECEIVABLES>                           0
<ASSETS-OTHER>                     15,177
<OTHER-ITEMS-ASSETS>                7,134
<TOTAL-ASSETS>                 17,282,212
<PAYABLE-FOR-SECURITIES>                0
<SENIOR-LONG-TERM-DEBT>                 0
<OTHER-ITEMS-LIABILITIES>         517,678
<TOTAL-LIABILITIES>               517,678
<SENIOR-EQUITY>                         0
<PAID-IN-CAPITAL-COMMON>       12,976,809
<SHARES-COMMON-STOCK>             400,000
<SHARES-COMMON-PRIOR>             400,000
<ACCUMULATED-NII-CURRENT>               0
<OVERDISTRIBUTION-NII>                  0
<ACCUMULATED-NET-GAINS>                 0
<OVERDISTRIBUTION-GAINS>                0
<ACCUM-APPREC-OR-DEPREC>        3,787,775
<NET-ASSETS>                   16,764,584
<DIVIDEND-INCOME>                       0
<INTEREST-INCOME>                  28,504
<OTHER-INCOME>                          0
<EXPENSES-NET>                    687,249
<NET-INVESTMENT-INCOME>          (658,745)
<REALIZED-GAINS-CURRENT>           93,889
<APPREC-INCREASE-CURRENT>         688,448
<NET-CHANGE-FROM-OPS>             123,592
<EQUALIZATION>                          0
<DISTRIBUTIONS-OF-INCOME>               0
<DISTRIBUTIONS-OF-GAINS>                0
<DISTRIBUTIONS-OTHER>                   0
<NUMBER-OF-SHARES-SOLD>                 0
<NUMBER-OF-SHARES-REDEEMED>             0
<SHARES-REINVESTED>                     0
<NET-CHANGE-IN-ASSETS>            123,592
<ACCUMULATED-NII-PRIOR>                 0
<ACCUMULATED-GAINS-PRIOR>               0
<OVERDISTRIB-NII-PRIOR>                 0
<OVERDIST-NET-GAINS-PRIOR>              0
<GROSS-ADVISORY-FEES>              83,070
<INTEREST-EXPENSE>                      0
<GROSS-EXPENSE>                   687,849
<AVERAGE-NET-ASSETS>           16,702,788
<PER-SHARE-NAV-BEGIN>                  33
<PER-SHARE-NII>                        (1)
<PER-SHARE-GAIN-APPREC>                 0 <F1>
<PER-SHARE-DIVIDEND>                    0
<PER-SHARE-DISTRIBUTIONS>               0
<RETURNS-OF-CAPITAL>                    0
<PER-SHARE-NAV-END>                    32
<EXPENSE-RATIO>                       4.1
<FN>
<F1>
A zero value is used since the change in net unrealized fair value is not
allocated to General Partners and Limited Partners as it is not taxable.
</FN>

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission